This is an active lawsuit, and none of the allegations against the defendant(s) have been proven. The contents of this page reflect the allegations in the lawsuits.
If you have experienced serious health complications after taking Ozempic for weight loss, you may be eligible to file an Ozempic lawsuit. Thousands of patients have already filed lawsuits involving Ozempic and other GLP-1 weight loss drugs—and, in these lawsuits, they are seeking compensation for conditions including gastroparesis (stomach paralysis) and non-arteritic anterior ischemic optic neuropathy (NAION), among others.
Lawsuits involving Ozempic and other popular GLP-1 weight loss drugs are being consolidated in federal multidistrict litigation (MDL) in the Eastern District of Pennsylvania. However, patients nationwide are eligible to file. For patients who have questions about joining the Ozempic litigation after receiving a diagnosis from their healthcare provider, it will be well worth scheduling a free consultation to learn about their legal rights.
“In the ongoing GLP-1 weight loss drug MDL, plaintiffs allege that Novo Nordisk and other drug manufacturers failed to adequately warn consumers about the risks associated with their drugs. Plaintiffs are seeking compensation for their medical costs incurred as a result of taking Ozempic as well as various other financial and non-financial losses.” – Dr. Nick Oberheiden, Founding Attorney of Oberheiden P.C.
The national GLP-1 weight loss drug MDL is still in its early stages. However, the judge is keeping the litigation moving forward swiftly, and it has been growing rapidly in recent months. As more Ozempic users come forward and seek financial compensation, Ozempic cases will receive greater attention, and Novo Nordisk will face greater financial pressure to consider a settlement.
10 Key Facts About Ozempic Lawsuits for Patients and Their Families
If you have been diagnosed with gastroparesis (stomach paralysis), other severe gastrointestinal injuries, NAION, or hair loss after taking Ozempic, what do you need to know about joining the MDL in federal court? Here are 10 key facts about Ozempic lawsuits for patients and their families:
1. Ozempic Lawsuits Filed to Date Primarily Involve Gastroparesis and NAION Claims
The majority of the Ozempic lawsuits filed to date fall into two categories: (i) Ozempic gastroparesis lawsuits; and, (ii) Ozempic vision loss lawsuits involving NAION. Patients who have been diagnosed with gastroparesis (stomach paralysis), NAION, or vision loss after being prescribed Ozempic for weight loss or chronic weight management by their healthcare providers account for the substantial majority of the plaintiffs in the ongoing pharmaceutical litigation against Novo Nordisk and its competitors.
Many of these plaintiffs allege that they suffered severe gastroparesis, serious gastrointestinal injuries, or permanent vision loss. These are life-altering conditions that can have significant financial and non-financial costs. As a result, the Ozempic lawyers representing these plaintiffs are seeking substantial compensation for their medical expenses, pain and suffering, and other losses.
2. Hair Loss Claims Are Also Under Investigation
While the substantial majority of the pending Ozempic lawsuits involve claims for gastroparesis and NAION (including vision loss), hair loss claims are also under investigation. If you have medical records linking your hair loss to taking Ozempic, it will be worth talking to a lawyer to find out if you are eligible to join the federal multidistrict litigation (MDL) involving Ozempic and other GLP-1 weight loss drugs (commonly referred to as the “Ozempic MDL”).
3. Lawsuits Are Being Consolidated in National Multidistrict Litigation (MDL) Involving Ozempic and Other GLP-1 Weight Loss Drugs
Ozempic lawsuits against Novo Nordisk involving claims for gastroparesis (stomach paralysis), non-arteritic anterior ischemic optic neuropathy (NAION), and other conditions are being consolidated in the national GLP-1 weight loss drug MDL in federal court. This has a number of advantages for plaintiffs alleging that Novo Nordisk failed to warn patients about increased risks that could—and arguably should—have been disclosed following clinical trials.
Among other things, consolidating federal lawsuits in an MDL proceeding provides access to consolidated pretrial proceedings—which helps streamline the process. Plaintiffs’ Ozempic lawyers can also share information uncovered through discovery, and they can leverage the scope of the litigation in settlement negotiations.
4. More Than 2,600 Plaintiffs Have Filed Ozempic Lawsuits and Others in the MDL
According to the Judicial Panel on Multidistrict Litigation (JPML), more than 2,600 plaintiffs have filed lawsuits (including, but not limited to, Ozempic lawsuits) in the national MDL as of September 2, 2025. The number of plaintiffs claiming damages in Ozempic lawsuits has been increasing steadily in recent months. Again, this includes primarily plaintiffs with gastroparesis claims and NAION claims, although plaintiffs are seeking compensation for other complications as well.
As the MDL in the Eastern District of Pennsylvania continues to grow, some Ozempic lawyers are filing their clients’ claims in state court as well. For example, many law firms are pursuing claims related to non-arteritic anterior ischemic optic neuropathy (NAION) in New Jersey state court. When you hire a lawyer to help you file an Ozempic lawsuit, your lawyer will advise you regarding where it makes the most sense to file your claim.
5. Filing an Ozempic Claim Requires a Confirmed Health Issue Documented with Medical Evidence
To file a claim, a patient who has been prescribed Ozempic for weight loss must have a confirmed health issue documented with medical evidence. With this in mind, those who have concerns and who have not yet sought a diagnosis should do so promptly. Abdominal pain, difficulty going to the bathroom, and vision impairments are just a few examples of signs that treatment may be necessary.
For patients with gastroparesis claims (including severe gastroparesis claims), filing an Ozempic lawsuit in the national GLP-1 weight loss drug MDL will require a gastric emptying study or an equivalent test. However, for other patients, specific testing requirements have not been established. Currently, in these cases, any medical records confirming diagnosis should be enough to substantiate a claim for just compensation.
6. Plaintiffs Are Seeking Evidence that Novo Nordisk was Aware of Undisclosed Increased Risks Through the Discovery Process
The national GLP-1 weight loss drug MDL is currently in the discovery phase. Through their lawyers, Ozempic users who have filed lawsuits are seeking to uncover evidence that Novo Nordisk was aware of undisclosed increased risks linked to Ozempic, whether through clinical trials, adverse event reports, or otherwise. If Novo Nordisk intentionally withheld information from patients and healthcare providers about the risk of severe gastrointestinal injuries, vision loss, or hair loss, this could potentially justify a demand for punitive damages.
7. Novo Nordisk’s Alleged Failure to Warn is Enough to Substantiate Claims for Ozempic Injuries
Importantly, however, evidence that Novo Nordisk knew about undisclosed increased risks linked to Ozempic is not required to establish liability. In this type of products liability litigation, it is enough to prove that the defendant failed to warn of serious health risk—whether it was aware of this risk or not. As a result, “failure to warn” claims are at the center of the ongoing Ozempic litigation; and, as these claims surge, Novo Nordisk’s liability exposure is continuing to grow.
But, while proof of a coverup is not required, establishing liability for failure to warn in products liability litigation is not easy. As a result, it is critical that all patients and family members who are pursuing Ozempic lawsuits have experienced legal representation.
8. Ozempic Lawsuits Involve Claims for Medical Bills and Other Losses
In the Ozempic lawsuits filed to date, plaintiffs argue that Novo Nordisk is fully responsible for their medical bills and other losses resulting from their Ozempic use. This includes, but is not limited to, losses such as:
- Medical expenses for diagnosing and treating gastroparesis, NAION, and other relevant health conditions
- Other out-of-pocket expenses such as transportation, prescription medications, and medical supplies
- Loss of income and benefits due to inability to work
- Pain, suffering, and emotional distress
- Loss of consortium, companionship, and enjoyment of life
If you have an Ozempic claim for gastroparesis, vision loss, or any other serious health condition, an experienced Ozempic lawyer will be able to determine how much you deserve to recover. Your lawyer will then be able to fight for the full compensation you deserve in the federal multidistrict litigation (MDL), or in state court if warranted.
9. It Costs Nothing Out-of-Pocket to Hire a Law Firm to File an Ozempic Lawsuit
If you have grounds to file an Ozempic lawsuit, it costs nothing out-of-pocket to hire a law firm to represent you. Law firms generally handle these types of cases against drug manufacturers on a contingency-fee basis, which means their clients’ legal fees (if any) are calculated as a percentage of the amount they recover. In these cases, the first step is to schedule a free consultation.
10. The GLP-1 Drug Multidistrict Litigation is Ongoing, and a Settlement is Not Guaranteed
Finally, while the plaintiffs in the national GLP-1 weight loss drug MDL (and the parallel state court litigation) appear to have strong claims for compensation, a settlement is not guaranteed. The Ozempic litigation still has a long way to go, and Novo Nordisk may never agree to settle. But, plaintiffs can take their claims to court if necessary; and, in any cases, if plaintiffs’ claims are successful, going through the process will be well worth it in the end.